chrisvoncsefalvay/vaers-outcomes huggingface dataset:
physical exam on 01Oct2021 that showed an elevated platelet count; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT INCREASED (physical exam on 01Oct2021 that showed an elevated platelet count) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021, the patient experienced PLATELET COUNT INCREASED (physical exam on 01Oct2021 that showed an elevated platelet count). At the time of the report, PLATELET COUNT INCREASED (physical exam on 01Oct2021 that showed an elevated platelet count) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Oct-2021, Platelet count: elevated platelet count (High) elevated platelet count.         No concomitant medications were reported. No treatment information was provided. Patient and parent are worried this may be contraindicated for the booster dose and their HCP instructed them to look at the CDC website patient is having difficulties to find the information
On 2/26/2021, I passed out on kitchen floor at 7:45 am, and was looking straight up with no movement. Husband shook and I snapped out of it and was taken to ER. While monitored in ER around 8:30am,  pulseless for 20 seconds and heart restarted on own. Pacemaker was determined to be needed. Pacemaker was inserted during that morning. Sick Sinus Syndrome was the diagnosis.
Localized 6x7 cm round area of blanching, slightly warm to touch wheal.  Developed about 24 hours after the injection.  No swelling of face, lips or tongue, no trouble breathing, no fevers, no axillary lymphadenopathy
Information has been received from a health care professional concerning a 23 year old male who was vaccinated with the 1st and 2nd dose of Hepatitis B vaccine recombinant. Subsequently, the patient developed swelling, pain, and a rash at the injection site. The rash was noted as being yellow and pus filled. The patient was noted as having this reaction after both shots, although "the second shot was a little less painful." The patient sought unspecified medical attention. Additional information has been requested.
FLUSHED; MINOR GOUT SWELLS; SORE ARM/THROBBING ARM; TIRED; SHORTNESS OF BREATH; ANXIETY; DIARRHEA WITH BLOOD; This spontaneous report received from a consumer concerned a 47 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included chronic gout.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205ANA, expiry: UNKNOWN) dose was not reported, 1 total administered on 08-MAY-2021 vaccination at left arm 16:30 for prophylactic vaccination. Concomitant medications included allopurinol for gout. On 08-May-2021, The patient experienced Shortness of breath shortly after vaccination, but this resolved in 15 minutes. He waited for 20 minutes after getting the vaccine. Patient noted that it could have been anxiety driven. On 08-May-2021 night (10 hours after), patient experienced diarrhea in the middle of the night and progressed to blood in the stool. The patient also very tired. Patient slept for almost 24 hours from Saturday to Sunday night, but now feels better. Patient felt very flushed, also experienced arm super sore for 1 day after vaccination, and throbbing for about an hour. The patient suffers from chronic gout and experienced minor gout swells (unsure if it is related to the vaccine or not) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shortness of breath, and anxiety on 08-MAY-2021, and sore arm/throbbing arm, and tired on 09-MAY-2021, was recovering from diarrhea with blood, had not recovered from minor gout swells, and the outcome of flushed was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210522256-COVID-19 VACCINE AD26.COV2.S-diarrhea with blood. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Shoulder injury related to vaccine administration (SIRVA). Patient unable to move shoulder, pain, and stiff. Patient was seen at urgent care and has a follow up appointment with medical doctor. Symptoms have persisted for the past month.
Severe pain at site starting by 1800 01/11/2021. 01/12/2021 Severe pain at site kept me awake most the night, headache, nausea, joint pain starting at 0615 01/12/2021 which continued to get worse through out the day. Left work early 01/12/2021. Woke 01/13/2021 with slight headache still.
10/11/04 Prednisone started. 10/14/04 Flu vaccine administered. 10/25/04 Complaints of chest pain; left arm feels funny, diaphoretic. 96.8, 72, 20, 142/80, out today. 10/27/04 Remains hospitalized. Discharge Summary received on 1/25/2005 states pt experienced thrombocytopenia and myocardial infarction. Follow up 01/26/05: Patient still has not recovered, has had several transfers to hospital since October for heart condition. As per annual follow up report: pt continues to have atrial Fib which she had history of prior to flu vaccine but was not an issue again until after vaccine. Questionable if vaccine caused reoccurrance of atrial Fib.
LUMP AT INJECTION SITE; TENDERNESS AT A POINT IN THE LUMP; This spontaneous report received from a pharmacist concerned a 42 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020 and expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced tenderness at a point in the lump. On 19-MAR-2021, the subject experienced lump at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at injection site and tenderness at a point in the lump was not reported. This report was non-serious.
Clinic did not see the email to stop giving original(monovalent) Pfizer 12+ until after these 3 shots were given  -1 given 9/1/22 and 2 given 9/2/22
Rt arm was aching, rt shoulder, back, lower limbs. Low grade fever 99.4 degrees F, was unable to get in and out of bathtub.
BAD Dizziness,  Rash & Bruising at injection site, (hot to the touch & Burning sensation .)  Headache,   spots in left eye,  I fell due to dizziness ..
This spontaneous report as received from a 74 year old consumer regarding himself. The patient had no drug reactions/allergies. The patient's current condition included a rash on his skin that felt like insect bites and itched miraculously. Approximately on an unknown date in 2012 (reproted as about a year ago), the patient was vaccinated with a dose of one time vaccination ZOSTAVAX (lot number, expiry date, route and ose were not reported) injection. Concomitant therapies included pravastatin sodium and fenofibrate. The rash was existed on his skin that felt like insect bites and itched miraculously went away on an unspecified date, within a week or so after having received ZOSTAVAX. Approximately on 27-AUG-2013 (reported as 2 weeks ago), the patient experienced a similar rash that returned. No medical attention was sought. Lab Diagnostics Studies were not Performed. The patient treated the more recent rash with apple cider vinegar and tumeric. Approximately on 08-SEP-2013 (reported as a couple days ago), the event rash was recovered/resolved. The outcome of a rash on his skin that felt like insect bites and itched miraculously went away within a week or so after having received ZOSTAVAX was unknown. Additional information has been requested.
runny nose; fever of 107; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and PYREXIA (fever of 107) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (fever of 107). On an unknown date, the patient experienced RHINORRHOEA (runny nose). At the time of the report, RHINORRHOEA (runny nose) and PYREXIA (fever of 107) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Pyrexia: 107 Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No relevant concomitant medications were reported.  No treatment information was provided.
This case was reported by a nurse via call center representative and described the occurrence of pain in arm in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patients received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patients experienced pain in arm and tiredness. On an unknown date, the outcome of the pain in arm and tiredness were recovered/resolved. It was unknown if the reporter considered the pain in arm and tiredness to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The age group was not reported, but was captured as adult as per the vaccine indication. The nurse casually mentioned that she had spoken to some patients who were vaccinated with SHINGRIX and they experienced soreness and fatigue that lasted for a day or so. The nurse did not have any other details. This was casually brought up while discussing another adverse events that were already reported.
Received bivalent vaccine today, reported after vaccine that she received one 10/15/22
42 days post first shot & has not received the 2nd shot; A little worst "hard time breathing" after first shot; Increased palpitation after first shot/Heart racing; Condition aggravated; This case was received via an unknown source (no reference has been entered for a regulatory authority or license partner) on 12-Oct-2021 and was forwarded to Moderna on 12-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (A little worst "hard time breathing" after first shot), PALPITATIONS (Increased palpitation after first shot/Heart racing), CONDITION AGGRAVATED (Condition aggravated) and PRODUCT DOSE OMISSION ISSUE (42 days post first shot & has not received the 2nd shot) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cardiovascular disorder (Heart problem), Palpitation (Heart Palpitation) and Dyspnea.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, the patient experienced DYSPNOEA (A little worst "hard time breathing" after first shot), PALPITATIONS (Increased palpitation after first shot/Heart racing) and CONDITION AGGRAVATED (Condition aggravated). On 12-Oct-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (42 days post first shot & has not received the 2nd shot). On 12-Oct-2021, PRODUCT DOSE OMISSION ISSUE (42 days post first shot & has not received the 2nd shot) had resolved. At the time of the report, DYSPNOEA (A little worst "hard time breathing" after first shot), PALPITATIONS (Increased palpitation after first shot/Heart racing) and CONDITION AGGRAVATED (Condition aggravated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Patient's regular cardiologist looked at her old records and recommended to get the second dose. EKG or any new tests were not performed.  Treatment information was not provided.
I had not shown any adverse reactions other than pain in the injection site on day one. One week after the first shot, I developed redness and swelling with pain at the injection site (approximately 3 inches in length by 1 inch in width).
Patient presented to the ED and was subsequently hospitalized for severe sepsis within 6 weeks of receiving covid booster vaccination.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported) and LIQUID PEDVAXHIB (Lot number, expiry date, route and dose were not reported). Medical assistant reported that both vaccines were exposed to temperature of 26 F (Fahrenheit) for a total of 135 hours. No adverse effects reported. Follow-up received. Certified Medical assistant stated other 104 children received GARDASIL and other 18 children received LIQUID PEDVAXHIB. Follow up information has been received from the certified medical assistant regarding a 15 years old, male patient with no pertinent medical history reported. On 27-AUG-2012 the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). Other suspect therapies included LIQUID PEDVAXHIB (lot number and expiration date not reported) (intramuscular on the left arm, dose not reported). On 18-MAR-2013 the patient received another dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the left arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
Pt received vaccine Friday (1/10/13), on Sat pt describes feeling of lightheadedness.  Patient went to ER and was treated for fever and dehydration. Symptoms of feeling drunk or intoxicated continued through Wednesday (1/15/13).
Patient was given first dose Moderna on 3/20/21 from spectrum health. Patient then came to get second dose Moderna on 7/7/21 and is outside the recommended 2nd dose vaccination window.
I felt strange about 30 minutes later. Fatigue set in but I was not able to fall asleep without a sleep aid for 3 weeks. My eyes and upper torso felt like they were on fire and my heart rate increased quite a bit. Site of injection very sore, but that's normal. Never had trouble sleeping before. Still not sleeping.
On December 2, 2020, I administered MMRV vaccine to the patient. On December 4, 2020, the mother, contacted the office to report the patient having temp of 101 F, redness, swelling, and hardness at the injection site (RA). She spoke with the RN who recommended to apply a cold compress to the injection site, and to give the patient Ibuprofen or Tylenol. On December 5, the patient followed-up with the patient's mother who reported the improvement in the patient's symptoms.
On 09/13/2000 the patient experienced a fever of 102F. On 09/13/2000 the patient experienced chicken pox with red vesicles on the abdomen and right leg. On 09/15/2000 the patient was diagnosed with chicken pox. On 09/18/2000 the patient developed a macular papular rash on her trunk and uniformly over her entire body. It was accompanied by fevers of up to 104F. The patient was diagnosed with viral exanthema. Medical attention was sought. The patient recovered as of 09/27/2000. No further information is available.
a patient received a dose of the Pfizer Covid-19 vaccine after it was diluted and left in the syringe in the fridge for 4 days; a patient received a dose of the Pfizer Covid-19 vaccine after it was diluted and left in the syringe in the fridge for 4 days; Received Vaccine that was punctured more than the time of 6 hours.; This is a spontaneous report from a contactable other hcp via Pfizer sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0179, Expiration Date: 31Aug2021), via an unspecified route of administration on 06Jul2021 as first dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received vaccine that was punctured more than the time of 6 hours on 06Jul2021 and received a dose of the Pfizer Covid-19 vaccine after it was diluted and left in the syringe in the fridge for 4 days. The reporter wanted to know if the patient needed to receive another Pfizer Covid 19 Vaccine immediately or if the Pfizer Covid 19 dose already administered was okay. The outcome of the events was unknown.; Sender's Comments: Based on the information provided, the association between the event production preparation error and the vaccination cannot be completely ruled out.
My COVID-19 symptoms started on 02/04/2023 also experienced heart pain, chest pain, racing heart beat that lasted approximately 5-6 weeks. I had severe headaches, muscles and pains, fatigue.  I went for a PCR test because all my home testes were negative. On day 4 I contacted my doctor who ordered a PCR test. On Day 6, my COVID-19 test was positive.  Because I had heart pain started around 02/02/2023 and I made an appointment with my doctor to talk to her about my heart pains. I was able to see my doctor who ordered a stress test and an echocardiogram on 03/23/2023.  My COVID-19 and heart issues might have related to the vaccine.  I have recovered about 90% but I did have a slight racing heart a couple of nights ago. My heart symptoms have dramatically decreased.   The stress test and echocardiogram came out fine as per my doctor.
Screaming and tachypneic starting the day after injection.  Hospitalized for one day.  8/19/08 Reviewed ER medical records of 8/6/2008. FINAL DX: tachypnea/colic vs vaccine reaction Records reveal patient experienced screaming inconsolably & having difficult breathing upon awakening.  Exam in ER was WNL but was admitted for observation.  No further episodes & d/c to home.
Rash, itching over whole body worse on upper legs & buttocks. Rash lasted for 2 wks. Treated with PO BENADRYL & topical hydrocortisone.
Patient received Gardasil and Menactra vaccinations on Friday, Feb. 27th at about 2 pm.  She also had completed a course of Zithromax, but had previously received 2 courses of this medication.  Patient felt fine throughout the weekend, but on Monday around 130 pm developed itching and slight rash.  Played golf from 4-5 pm and rash worsened with sweating.  That evening her mother gave her diphenhydramine and Calamine lotion which helped the rash decrease in size and decreased pruritis associated with the rash.  On Tuesday morning the rash was very light, but again worsened throughout the day and greatly increased in size after golf from 4-5 pm.  Mother described rash as now spread throughout body including abdomen, breasts, back, neck, and palms of hands and soles of feet.  Patient began having breathing difficulties and was brought to an urgent care facility around 7 pm.  She received epinephrine and IV methylprednisolone and was discharged after the breathing improved and the rash decreased in size.  At about 1230 am that night the patient again experienced breathing difficulites and worsened rash and presented to the ER.  She was given another dose of epi, IV steroids, and antihistamines.  Patient was sent home after improvement, but again presented Wed am, this time to the TEC.  Patient was admitted and received 2 more rounds of epi, scheduled methylprednisolone (25 mg IV q6h), scheduled hydroxyzine (50 mg po q6h), and Pepcid (20 mg IV q12h).  Patient weighed 54.2 kg.  Patient was discharged on Friday March 6th with an epi pen, prn hydroxyzine, oral steroids, H2 antag, etc.  Medical residents described rash as hives.  Patient reported no changes to diet or unusual outdoor triggers.  When looking at literature, it appeared the majority of documented cases with Menactra were within 24hrs, but when looking at a study of Australian teenage girls receiving Gardasil, it appeared several of the cases were delayed in nature (up to a several days).  Please contact PharmD for literature links.  We felt given history of Zithromax and the literature made Gardasil most likely contributing factor.  Unknown lot numbers of immun. as they were given at clinic.  Please contact representative with questions or pediatric clinic for lot #'s.  4/10/09 Received hospital medical records of 3/4-3/6/2009. FINAL DX: anaphylaxis, resolved, suspect Gardasil reaction. Records reveal patient experienced intermittent hives, itching, chest pain & respiratory distress.  Had been seen in urgent care x 3 for same over 2 days & tx w/epi & oral steroids & antihistamine.  Noted to have dyspnea, tachypnea & stridor on admit.  Tx w/IV epi, steroids & antihistamines.  Improved & d/c to home on tapering steroids, epi pen & w/instruction for allergy referral.
c/o bad h/a,dizziness&an inc temp evening of vax;sx persisted for 2 days;had nose bleeds x 4 2-4 days p/vax;saturated a tissue each time
Itching on arm where vaccine was given; Welt on arm where vaccine was given; Red where vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on arm where vaccine was given), VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) and INJECTION SITE ERYTHEMA (Red where vaccine was given) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Patient's medical history included No Adverse event.     On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on arm where vaccine was given), VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) and INJECTION SITE ERYTHEMA (Red where vaccine was given). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 11-Mar-2021, VACCINATION SITE PRURITUS (Itching on arm where vaccine was given) and VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Red where vaccine was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported
The pt reported on 1/16/02 of experiencing redness and swelling of orbits of eyes and eyelids which resolved in 2 weeks. The redness and swelling and eventual flaking of skin around mouth resolved in 3 weeks. Vaginitis resolved in 3 days. Did not seek medical help. No meds.
Transient, migratory mild urticaria of upper and lower extremities beginning 5 days after receiving the Moderna COVID19 booster. Recurrence is sporadic and infrequent with symptoms resolving within a few hours without treatment during each episode. An isolated episode of angioedema of the lips occurred 6 weeks after the date of vaccination and was self-treated with diphenhydramine, loratadine, and a topical corticosteroid with resolution within 24 hours. No prior history of similar symptoms, allergies, or drug reactions.
for the moderna booster I gave 0.5mL , when it should have been 0.25mL . spoke with the patient and patient stated they are ok